Tags: Heart Disease | FDA Samsca Blood Drug Liver Injury

FDA: Samsca Blood Drug Tied to Liver Injury

Friday, 01 Mar 2013 04:27 PM

By Nick Tate

The U.S. Food and Drug Administration has issued a warning to healthcare professionals that the drug Samsca — used to raise sodium levels in the blood of people with heart disease and liver problems — “has the potential to cause irreversible and potentially fatal liver injury.”
Samsca (Tolvaptan) is a drug used to treat hypervolemic and euvolemic hyponatremia — a lack of salt in body fluids.
The FDA’s warning was made along with Otsuka America Pharmaceutical Inc., which distributes and markets the drug Samsca, after liver injury was found in patients treated with the drug as part of a large clinical trial. Three of the 1,400 patients in the study experienced increases in liver enzymes, which may indicate serious liver damage, mostly during the first 18 months of the three-year study.
Samsca is a prescription medicine used to help increase low sodium levels in the blood in adults with conditions such as heart failure, liver disease and certain hormone imbalances.
FDA experts advised anyone who has taken Samsca to consult a doctor about any of the following symptoms of liver injury: tiredness, anorexia, abdominal discomfort, dark urine, or yellowing of the skin.
The FDA recommended healthcare providers perform liver tests promptly for patients taking the drug who report symptoms and, if damage is confirmed, discontinue its use.

© 2015 NewsmaxHealth. All rights reserved.

Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
Zip Code:
Privacy: We never share your email.
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

A-Fib Found to Double 'Silent' Stroke Risk

Monday, 24 Nov 2014 14:14 PM

Atrial fibrillation, a common condition in which the heart beats irregularly, more than doubles the risk of "silent stro . . .

Drug to Treat Hemophilia

Friday, 24 Oct 2014 12:48 PM

Drugmaker Baxter International Inc said the U.S. Food and Drug Administration had approved its drug for treating bleedin . . .

4 Things You Need to Know About This Year's Flu Shot

Thursday, 04 Sep 2014 10:58 AM

At this point, scientists say they can't predict the severity of the coming flu season. But if you are planning to get t . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

America's News Page
©  Newsmax Media, Inc.
All Rights Reserved